Please assess the completion status of the following clinical trial:

Trial Title: Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Any newly diagnosed patient at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute whose Hematologist or Oncologist has ordered them to undergo a bilateral bone marrow biopsy for diagnostic and /or treatment purposes.~* 18 years of age or older.~Exclusion Criteria:~* Pregnant or Lactating women.~* Patients with allergies to local anesthetics.~* Patients requiring a unilateral bone marrow biopsy.~* Patients that cannot lie flat in either the supine or prone position.~* Patients that have used any of the following: narcotics, non-narcotic analgesia or an anti-anxiolytic medication on the same calendar day as the scheduled procedure. These medications will not be given to the participant at any time before or during the procedure.~* Patients on long-acting narcotic medication.~* Patients with neuropathy in the posterior iliac crest area~* Patients with a platelet count less than 20,000.~* Patients who are cognitively impaired or unable to self-report pain using the VAS.~* Patients with known bone metastasis.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- buffered lidocaine (Type: EXPERIMENTAL): Sodium bicarbonate is a buffering additive that decreases the pH of the solution allowing for decrease in pain upon filtration.
- unbuffered lidocaine (Type: EXPERIMENTAL): lidocaine is injected without sodium bicarbonate added

Based on this trial design, predict the completion outcome and termination type (if applicable).